Related Experiment Videos
Leber's hereditary opric neuropathy: a case report
Chi-Wu Chang1, Chi-Huang Chang, Mei-Lin Peng
1Department of Ophthalmology, Chung Shan Medical University, Taichung, Taiwan.
The Kaohsiung Journal of Medical Sciences
|November 19, 2003
Summary
Leber's hereditary optic neuropathy (LHON) is a mitochondrial disease causing vision loss. Genetic testing identified the 11778 mutation, confirming LHON in a young patient treated with Coenzyme Q10.
Area of Science:
- Ophthalmology
- Genetics
- Neurology
Background:
- Leber's hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disease.
- It primarily affects young individuals, causing bilateral vision loss.
Observation:
- A 12-year-old boy presented with over a year of blurred vision.
- Ophthalmologic exams revealed optic disc abnormalities and visual field defects.
- Mitochondrial DNA analysis detected the specific 11778 point mutation.
Findings:
- The patient was diagnosed with Leber's hereditary optic neuropathy (LHON).
- The 11778 mutation in mitochondrial DNA was confirmed as the cause.
- Coenzyme Q10 was administered as a therapeutic intervention.
Implications:
- This case highlights the importance of genetic testing in diagnosing LHON.
- Early diagnosis and potential treatment with Coenzyme Q10 may impact patient outcomes.
- Understanding the genetic basis of LHON is crucial for developing targeted therapies.